|
|
9 A.M. EDT, November 02, 2007
Ensil Canada Ltd. announced today the validation of a 5 minute, non invasive HIV
test at its laboratories in Ontario Canada.
"After several years of scientific and biomedical laboratory experiments by
Ensil Canada Ltd. Scientific team of researchers, we are extremely proud to make
this announcement" said Farsad Kiani, Chief Executive Officer of Ensil Canada
Ltd.
Kiani continued, "When Ensil Canada Ltd. diagnostic device is put on the market,
high risk groups may get tested at more convenient locations as a do it
yourself, real time, cost effective way to test and receive their own test
results in strictest confidence"
Ensil Canada Ltd. Chief Scientist and the lead project CSO added after the
successful experiments with the antibody to HIV gp41 Ensil will try to validate
the same results with gp120 so a wide range of HIV strain could be detected"
9 A.M. EDT, April 24, 2007
Toronto, Canada, Ensil Canada Ltd. announced today that it has entered into a
biomedical research and development partnership with a major Canadian University
in Ontario, Canada.
Ensil's scientific staff will co-locate with academic faculty staff of the
university to continue promising medical research that has been proven by small
scale initial experimentation and validation.
Farsad Kiani, President and CEO of Ensil Canada Ltd. said, "This is an excellent
partnership. University staff is being updated by the newer commercial
instrumentation innovations in the area of chemicals and proteins detection
through urine with the technology developed by Ensil. Ensil benefits by the
guidance and oversight of world class academics to further explore the
scientific possibilities of this innovation."
|
|